Connecting transcriptional control to chromosome structure and human disease

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 75, Issue , 2010, Pages 227-235

  Newman, J J ^a   Young, R A ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BETA INTERFERON; BONE MORPHOGENETIC PROTEIN 4; COHESIN; CYCLIC AMP; CYCLIC AMP BINDING PROTEIN; DNA BINDING PROTEIN; INTERLEUKIN 6; JANUS KINASE; KRUPPEL LIKE FACTOR 4; LAC REPRESSOR; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; RNA POLYMERASE; SMAD PROTEIN; STAT PROTEIN; STAT3 PROTEIN; T CELL FACTOR 3; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7 LIKE 1; TRANSCRIPTION FACTOR ESRRB; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR RONIN; TRANSCRIPTION FACTOR SALL4; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TRIM28; UNCLASSIFIED DRUG; WNT PROTEIN; DNA; MEDIATOR COMPLEX;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CHROMOSOME STRUCTURE; DEVELOPMENTAL DISORDER; EMBRYONIC STEM CELL; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENETIC PROCEDURES; GENETIC VARIABILITY; HISTONE MODIFICATION; HUMAN; INNER CELL MASS; LACTOSE OPERON; ONCOGENE C MYC; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; DISEASES; GENE ACTIVATION; HISTORICAL RESEARCH; NONHUMAN; NUCLEAR REPROGRAMMING; PROMOTER REGION;

CHROMOSOMES, HUMAN; DISEASE; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; HUMANS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 80052413587     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2010.75.016     Document Type: Article

References (152)

1. Agalioti T, Lomvardas S, Parekh B, Yie J, Maniatis T, Thanos D. 2000. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-β promoter. Cell 103: 667-678.
2. Agger K, Christensen J, Cloos PA, Helin K. 2008. The emerging functions of histone demethylases. Curr Opin Genet Dev 18: 159-168.
3. Ambrosetti DC, Basilico C, Dailey L. 1997. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol Cell Biol 17: 6321-6329.
4. Ambrosetti DC, Scholer HR, Dailey L, Basilico C. 2000. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J Biol Chem 275: 23387-23397.
5. Aubert J, Dunstan H, Chambers I, Smith A. 2002. Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat Biotechnol 20: 1240-1245.
6. Auernhammer CJ, Melmed S. 2000. Leukemia-inhibitory factorneuroimmune modulator of endocrine function. Endocr Rev 21: 313-345.
7. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. 2003. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17: 126-140.
8. Ayyanathan K, Lechner MS, Bell P, Maul GG, Schultz DC, Yamada Y, Tanaka K, Torigoe K, Rauscher FJ III. 2003. Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: A mammalian cell culture model of gene variegation. Genes Dev 17: 1855-1869.
9. Babu MM, Luscombe NM, Aravind L, Gerstein M, Teichmann SA. 2004. Structure and evolution of transcriptional regulatory networks. Curr Opin Struct Biol 14: 283-291.
10. Banerji J, Rusconi S, Schaffner W. 1981. Expression of a β-globin gene is enhanced by remote SV40 DNA sequences. Cell 27: 299-308.
11. Benoist C, Chambon P. 1981. In vivo sequence requirements of the SV40 early promotor region. Nature 290: 304-310.
12. Berger SL. 2002. Histone modifications in transcriptional regulation. Curr Opin Genet Dev 12: 142-148.
13. Bernstein BE, Liu CL, Humphrey EL, Perlstein EO, Schreiber SL. 2004. Global nucleosome occupancy in yeast. Genome Biol 5: R62.
14. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, et al. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
15. Bilodeau S, Kagey MH, Frampton GM, Rahl PB, Young RA. 2009. SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev 23: 2484-2489.
16. Borck G, Redon R, Sanlaville D, Rio M, Prieur M, Lyonnet S, Vekemans M, Carter NP, Munnich A, Colleaux L, et al. 2004. NIPBL mutations and genetic heterogeneity in Cornelia de Lange syndrome. J Med Genet 41: e128.
17. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, et al. 2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956.
18. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK, et al. 2006. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441: 349-353.
19. Breiling A, Sessa L, Orlando V. 2007. Biology of polycomb and trithorax group proteins. Int Rev Cytol 258: 83-136.
20. Cairns BR. 2009. The logic of chromatin architecture and remodelling at promoters. Nature 461: 193-198.
21. Chambers I, Smith A. 2004. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23: 7150-7160.
22. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. 2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655.
23. Chen X, Vega VB, Ng HH. 2008a. Transcriptional regulatory networks in embryonic stem cells. Cold Spring Harb Symp Quant Biol 73: 203-209.
24. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J, et al. 2008b. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133: 1106-1117.
25. Cole MF, Johnstone SE, Newman JJ, Kagey MH, Young RA. 2008. Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev 22: 746-755.
26. Conaway RC, Sato S, Tomomori-Sato C, Yao T, Conaway JW. 2005. The mammalian Mediator complex and its role in transcriptional regulation. Trends Biochem Sci 30: 250-255.
27. Daheron L, Opitz SL, Zaehres H, Lensch MW, Andrews PW, Itskovitz-Eldor J, Daley GQ. 2004. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22: 770-778.
28. D'Alessio JA, Wright KJ, Tjian R. 2009. Shifting players and paradigms in cell-specific transcription. Mol Cell 36: 924-931.
29. Davey CA, Sargent DF, Luger K, Maeder AW, Richmond TJ. 2002. Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 Å resolution. J Mol Biol 319: 1097-1113.
30. Dejosez M, Levine SS, Frampton GM, Whyte WA, Stratton SA, Barton MC, Gunaratne PH, Young RA, Zwaka TP. 2010. Ronin/Hcf-1 binds to a hyperconserved enhancer element and regulates genes involved in the growth of embryonic stem cells. Genes Dev 24: 1479-1484.
31. de la Serna IL, Ohkawa Y, Higashi C, Dutta C, Osias J, Kommajosyula N, Tachibana T, Imbalzano AN. 2006a. The microphthalmia- associated transcription factor requires SWI/SNF enzymes to activate melanocyte-specific genes. J Biol Chem 281: 20233-20241.
32. de la Serna IL, Ohkawa Y, Imbalzano AN. 2006b. Chromatin remodelling in mammalian differentiation: Lessons from ATPdependent remodellers. Nat Rev Genet 7: 461-473.
33. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, et al. 2008. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218-1221.
34. Ding N, Zhou H, Esteve PO, Chin HG, Kim S, Xu X, Joseph SM, Friez MJ, Schwartz CE, Pradhan S, et al. 2008. Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation. Mol Cell 31: 347-359.
35. Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, Thomson JA, Svendsen CN. 2009. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457: 277-280.
36. Faust C, Lawson KA, Schork NJ, Thiel B, Magnuson T. 1998. The Polycomb-group gene eed is required for normal morphogenetic movements during gastrulation in the mouse embryo. Development 125: 4495-4506.
37. Finch JT, Klug A. 1976. Solenoidal model for superstructure in chromatin. Proc Natl Acad Sci 73: 1897-1901.
38. Fuda NJ, Ardehali MB, Lis JT. 2009. Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature 461: 186-192.
39. Gerber M, Shilatifard A. 2003. Transcriptional elongation by RNA polymerase II and histone methylation. J Biol Chem 278: 26303-26306.
40. Gilbert N, Boyle S, Fiegler H, Woodfine K, Carter NP, Bickmore WA. 2004. Chromatin architecture of the human genome: Generich domains are enriched in open chromatin fibers. Cell 118: 555-566.
41. Goetze S, Mateos-Langerak J, van Driel R. 2007. Three-dimensional genome organization in interphase and its relation to genome function. Semin Cell Dev Biol 18: 707-714.
42. Hampsey M, Reinberg D. 1999. RNA polymerase II as a control panel for multiple coactivator complexes. Curr Opin Genet Dev 9: 132-139.
43. Hart AH, Hartley L, Ibrahim M, Robb L. 2004. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn 230: 187-198.
44. Hassig CA, Schreiber SL. 1997. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr Opin Chem Biol 1: 300-308.
45. Hilton DJ. 1992. LIF: Lots of interesting functions. Trends Biochem Sci 17: 72-76.
46. Ho L, Crabtree G.R. 2010. Chromatin remodelling during development. Nature 463: 474-484.
47. Hu G, Kim J, Xu Q, Leng Y, Orkin SH, Elledge SJ. 2009. A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev 23: 837-848.
48. Humphrey RK, Beattie GM, Lopez AD, Bucay N, King CC, Firpo MT, Rose-John S, and Hayek A. 2004. Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells 22: 522-530.
49. Jacob F, Monod J. 1961. Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol 3: 318-356.
50. Jaenisch R, Young R. 2008. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132: 567-582.
51. Jiang C, Pugh BF. 2009. Nucleosome positioning and gene regulation: Advances through genomics. Nat Rev Genet 10: 161-172.
52. Kagey MH, Newman JJ, Bilodeau S, Zhan Y, van Berkum NL, Orlando DA, Ebmeier CC, Goossens J, Rahl P, Levine SS, et al. 2010. Mediator and cohesin connect gene expression and chromatin architecture. Nature 467: 430-435.
53. Kielman MF, Rindapaa M, Gaspar C, van Poppel N, Breukel C, van Leeuwen S, Taketo MM, Roberts S, Smits R, Fodde R. 2002. Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling. Nat Genet 32: 594-605.
54. Kim JK, Samaranayake M, Pradhan S. 2009. Epigenetic mechanisms in mammals. Cell Mol Life Sci 66: 596-612.
55. Kingston RE, Narlikar GJ. 1999. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev 13: 2339-2352.
56. Kiskinis E, Eggan K. 2010. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 120: 51-59.
57. Kornberg RD. 2005. Mediator and the mechanism of transcriptional activation. Trends Biochem Sci 30: 235-239.
58. Kornberg RD, Klug A. 1981. The nucleosome. Sci Am 244: 52-64.
59. Kouzarides T. 2000. Acetylation: A regulatory modification to rival phosphorylation? EMBO J 19: 1176-1179.
60. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128: 693-705.
61. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860-921.
62. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, Chevalier B, Johnstone SE, Cole MF, Isono K, et al. 2006. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301-313.
63. Levine M, Tjian R. 2003. Transcription regulation and animal diversity. Nature 424: 147-151.
64. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, et al. 2006. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38: 431-440.
65. Lohmann F, Loureiro J, Su H, Fang Q, Lei H, Lewis T, Yang Y, Labow M, Li E, Chen T, et al. 2010. KMT1E mediated H3K9 methylation is required for the maintenance of embryonic stem cells by repressing trophectoderm differentiation. Stem Cells 28: 201-212.
66. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. 1997. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389: 251-260.
67. Maherali N, Hochedlinger K. 2008. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3: 595-605.
68. Maherali N, Hochedlinger K. 2009. Tgfβ signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr Biol 19: 1718-1723.
69. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, et al. 2007. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55-70.
70. Malik S, Roeder RG. 2005. Dynamic regulation of pol II transcription by the mammalian mediator complex. Trends Biochem Sci 30: 256-263.
71. Malik S, Roeder RG. 2008. Epigenetics? Mediator does that too! Mol Cell 31: 305-306.
72. Maniatis T, Goodbourn S, Fischer JA. 1987. Regulation of inducible and tissue-specific gene expression. Science 236: 1237-1245.
73. Maniatis T, Falvo JV, Kim TH, Kim TK, Lin CH, Parekh BS, Wathelet MG. 1998. Structure and function of the interferon-β enhanceosome. Cold Spring Harb Symp Quant Biol 63: 609-620.
74. Marson A, Foreman R, Chevalier B, Bilodeau S, Kahn M, Young RA, Jaenisch R. 2008. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 3: 132-135.
75. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, Okochi H, Okuda A, Matoba R, Sharov AA, et al. 2007. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9: 625-635.
76. Mavrich TN, Jiang C, Ioshikhes IP, Li X, Venters BJ, Zanton SJ, Tomsho LP, Qi J, Glaser RL, Schuster SC, et al. 2008. Nucleosome organization in the Drosophila genome. Nature 453: 358-362.
77. McKenna NJ, O'Malley BW. 2002. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465-474.
78. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. 2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642.
79. Musio A, Selicorni A, Focarelli ML, Gervasini C, Milani D, Russo S, Vezzoni P, Larizza L. 2006. X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations. Nat Genet 38: 528-530.
80. Naar AM, Lemon BD, Tjian R. 2001. Transcriptional coactivator complexes. Annu Rev Biochem 70: 475-501.
81. Narlikar L, Ovcharenko I. 2009. Identifying regulatory elements in eukaryotic genomes. Brief Funct Genomic Proteomic 8: 215-230.
82. Narlikar GJ, Fan HY, Kingston RE. 2002. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108: 475-487.
83. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95: 379-391.
84. Nichols J, Chambers I, Taga T, Smith A. 2001. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 128: 2333-2339.
85. O'Carroll D, Erhardt S, Pagani M, Barton SC, Surani MA, Jenuwein T. 2001. The Polycomb-group gene Ezh2 is required for early mouse development. Mol Cell Biol 21: 4330-4336.
86. Okita K, Yamanaka S. 2006. Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Curr Stem Cell Res Ther 1: 103-111.
87. Olins AL, Olins DE. 1974. Spheroid chromatin units (v bodies). Science 183: 330-332.
88. Orlando V. 2003. Polycomb, epigenomes, and control of cell identity. Cell 112: 599-606.
89. Pan G, Tian S, Nie J, Yang C, Ruotti V, Wei H, Jonsdottir GA, Stewart R, Thomson JA. 2007. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 1: 299-312.
90. Pan Y, Tsai CJ, Ma B, Nussinov R. 2010. Mechanisms of transcription factor selectivity. Trends Genet 26: 75-83.
91. Panne D. 2008. The enhanceosome. Curr Opin Struct Biol 18: 236-242.
92. Park IH, Lerou PH, Zhao R, Huo H, Daley GQ. 2008a. Generation of human-induced pluripotent stem cells. Nat Protoc 3: 1180-1186.
93. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. 2008b. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146.
94. Pasini D, Bracken AP, Jensen MR, Lazzerini Denchi E, Helin K. 2004. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J 23: 4061-4071.
95. Philibert RA, Madan A. 2007. Role of MED12 in transcription and human behavior. Pharmacogenomics 8: 909-916.
96. Philibert RA, Bohle P, Secrest D, Deaderick J, Sandhu H, Crowe R, Black DW. 2007. The association of the HOPA(12bp) polymorphism with schizophrenia in the NIMH genetics initiative for schizophrenia sample. Am J Med Genet B Neuropsychiatr Genet 144B: 743-747.
97. Phillips DM. 1963. The presence of acetyl groups of histones. Biochem J 87: 258-263.
98. Pirrotta V. 1998. Polycombing the genome: PcG, trxG, and chromatin silencing. Cell 93: 333-336.
99. Reya T, Clevers H. 2005. Wnt signalling in stem cells and cancer. Nature 434: 843-850.
100. Ringrose L, Paro R. 2004. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 38: 413-443.
101. Ris H, Kubai DF. 1970. Chromosome structure. Annu Rev Genet 4: 263-294.
102. Risheg H, Graham JM Jr, Clark RD, Rogers RC, Opitz JM, Moeschler JB, Peiffer AP, May M, Joseph SM, Jones JR, et al. 2007. A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome. Nat Genet 39: 451-453.
103. Roeder RG. 1998. Role of general and gene-specific cofactors in the regulation of eukaryotic transcription. Cold Spring Harb Symp Quant Biol 63: 201-218.
104. Roeder RG. 2005. Transcriptional regulation and the role of diverse coactivators in animal cells. FEBS Lett 579: 909-915.
105. Roth SY, Denu JM, Allis CD. 2001. Histone acetyltransferases. Annu Rev Biochem 70: 81-120.
106. Saladi SV, de la Serna IL. 2010. ATP dependent chromatin remodeling enzymes in embryonic stem cells. Stem Cell Rev 6: 62-73.
107. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. 2004. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10: 55-63.
108. Scholer HR, Ruppert S, Suzuki N, Chowdhury K, Gruss P. 1990. New type of POU domain in germ line-specific protein Oct-4. Nature 344: 435-439.
109. Schones DE, Cui K, Cuddapah S, Roh TY, Barski A, Wang Z, Wei G, Zhao K. 2008. Dynamic regulation of nucleosome positioning in the human genome. Cell 132: 887-898.
110. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G. 2007. Genome regulation by polycomb and trithorax proteins. Cell 128: 735-745.
111. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ III. 2002. SETDB1: A novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 16: 919-932.
112. Schwartz YB, Pirrotta V. 2007. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 8: 9-22.
113. Schwartz CE, Tarpey PS, Lubs HA, Verloes A, May MM, Risheg H, Friez MJ, Futreal PA, Edkins S, Teague J, et al. 2007. The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene. J Med Genet 44: 472-477.
114. Segal E, Fondufe-Mittendorf Y, Chen L, Thastrom A, Field Y, Moore IK, Wang JP, Widom J. 2006. A genomic code for nucleosome positioning. Nature 442: 772-778.
115. Shi Y, Massagué J. 2003. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113: 685-700.
116. Sif S. 2004. ATP-dependent nucleosome remodeling complexes: Enzymes tailored to deal with chromatin. J Cell Biochem 91: 1087-1098.
117. Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW, Smith A. 2008. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 6: e253.
118. Smith TA, Hooper ML. 1983. Medium conditioned by feeder cells inhibits the differentiation of embryonal carcinoma cultures. Exp Cell Res 145: 458-462.
119. Smith SK, Charnock-Jones DS, Sharkey AM. 1998. The role of leukemia inhibitory factor and interleukin-6 in human reproduction. Hum Reprod (suppl 3) 13: 237-243 (discussion 244-246).
120. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, et al. 2009. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136: 964-977.
121. Spiegelman BM, Heinrich R. 2004. Biological control through regulated transcriptional coactivators. Cell 119: 157-167.
122. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell JE Jr, Yancopoulos GD. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267: 1349-1353.
123. Strachan T. 2005. Cornelia de Lange syndrome and the link between chromosomal function, DNA repair and developmental gene regulation. Curr Opin Genet Dev 15: 258-264.
124. Taatjes DJ, Tjian R. 2004. Structure and function of CRSP/Med2; a promoter-selective transcriptional coactivator complex. Mol Cell 14: 675-683.
125. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
126. Thiagalingam S, Cheng KH, Lee HJ, Mineva N, Thiagalingam A, Ponte JF. 2003. Histone deacetylases: Unique players in shaping the epigenetic histone code. Ann NY Acad Sci 983: 84-100.
127. Thomas MC, Chiang CM. 2006. The general transcription machinery and general cofactors. Crit Rev Biochem Mol Biol 41: 105-178.
128. Tirosh I, Barkai N. 2008. Two strategies for gene regulation by promoter nucleosomes. Genome Res 18: 1084-1091.
129. Trievel RC. 2004. Structure and function of histone methyltransferases. Crit Rev Eukaryot Gene Expr 14: 147-169.
130. Trounson A. 2009. New perspectives in human stem cell therapeutic research. BMC Med 7: 29.
131. Tsukiyama T, Wu C. 1995. Purification and properties of an ATPdependent nucleosome remodeling factor. Cell 83: 1011-1020.
132. Tsukiyama T, Daniel C, Tamkun J, Wu C. 1995. ISWI, a member of the SWI2/SNF2 ATPase family, encodes the 140 kDa subunit of the nucleosome remodeling factor. Cell 83: 1021-1026.
133. van den Berg DL, Zhang W, Yates A, Engelen E, Takacs K, Bezstarosti K, Demmers J, Chambers I, Poot RA. 2008. Estrogenrelated receptor β interacts with Oct4 to positively regulate Nanog gene expression. Mol Cell Biol 28: 5986-5995.
134. Verdin E, Dequiedt F, Kasler HG. 2003. Class II histone deacetylases: Versatile regulators. Trends Genet 19: 286-293.
135. Visel A, Rubin EM, Pennacchio LA. 2009. Genomic views of distant-acting enhancers. Nature 461: 199-205.
136. Wang H, An W, Cao R, Xia L, Erdjument-Bromage H, Chatton B, Tempst P, Roeder RG, Zhang Y. 2003. mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression. Mol Cell 12: 475-487.
137. Wasylyk B, Wasylyk C, Augereau P, Chambon P. 1983. The SV40 72 bp repeat preferentially potentiates transcription starting from proximal natural or substitute promoter elements. Cell 32: 503-514.
138. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R. 2007. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-324.
139. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R. 2008. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci 105: 5856-5861.
140. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA, Gough NM. 1988. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684-687.
141. Wu Q, Chen X, Zhang J, Loh YH, Low TY, Zhang W, Sze SK, Lim B, Ng HH. 2006. Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells. J Biol Chem 281: 24090-24094.
142. Yang XJ, Seto E. 2007. HATs and HDACs: From structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26: 5310-5318.
143. Yeap LS, Hayashi K, Surani MA. 2009. ERG-associated protein with SET domain (ESET)-Oct4 interaction regulates pluripotency and represses the trophectoderm lineage. Epigenetics Chromatin 2: 12.
144. Yeates TO. 2002. Structures of SET domain proteins: Protein lysine methyltransferases make their mark. Cell 111: 5-7.
145. Ying QL, Smith AG. 2003. Defined conditions for neural commitment and differentiation. Methods Enzymol 365: 327-341.
146. Yoshikawa Y, Fujimori T, McMahon AP, Takada S. 1997. Evidence that absence of Wnt-3a signaling promotes neuralization instead of paraxial mesoderm development in the mouse. Dev Biol 183: 234-242.
147. Yuan GC, Liu YJ, Dion MF, Slack MD, Wu LF, Altschuler SJ, Rando OJ. 2005. Genome-scale identification of nucleosome positions in S. cerevisiae. Science 309: 626-630.
148. Yuan P, Han J, Guo G, Orlov YL, Huss M, Loh YH, Yaw LP, Robson P, Lim B, Ng HH. 2009. Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells. Genes Dev 23: 2507-2520.
149. Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY, Soh BS, Lou Y, Yang J, Ma Y, Chai L, et al. 2006. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol 8: 1114-1123.
150. Zhang B, Jain S, Song H, Fu M, Heuckeroth RO, Erlich JM, Jay PY, Milbrandt J. 2007. Mice lacking sister chromatid cohesion protein PDS5B exhibit developmental abnormalities reminiscent of Cornelia de Lange syndrome. Development 134: 3191-3201.
151. Zhang X, Zhang J, Wang T, Esteban MA, Pei D. 2008. Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells. J Biol Chem 283: 35825-35833.
152. Zhao XD, Han X, Chew JL, Liu J, Chiu KP, Choo A, Orlov YL, Sung WK, Shahab A, Kuznetsov VA, et al. 2007. Wholegenome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 1: 286-298.